The largest community of pharma leaders

BMS, GSK and Astellas join OKRA to discuss the answer to uncertainty

We live in an increasingly digital world. Even more so following Covid-19. 

As our field forces transition to an online/hybrid model, we start to think not just about the disadvantages but the new advantages this brings.

One tempting possibility is the promise of ‘next best action’, using AI to give reps direction and guidance on who to approach and how to approach them.

However, like with all digital implementations, success or failure is dependent on ‘how’ you do it.

Listen to BMS, GSK and Astellas in a discussion with OKRA to discover the future of pharma sales and why, actually, simply going with ‘next best action’ may not be sufficient.

Listen to the discussion here

For more information or if you have any questions, please contact Rasim Shah, Director at OKRA on hello@okra.ai

This webinar has been featured by The Pharmaceutical Marketing Group. Interested in working with us? Contact our webinar division at info@pharmamkt.net

2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.